Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists scan brains of people with autism to understand sensory differences

NCT ID NCT00956579

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study used brain scans like MEG, EEG, and MRI to learn how the brains of people with autism spectrum disorder process sensory information. 85 people between the ages of 14 and 32 took part. The goal was to better understand the condition, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

85 people

The number who actually took part.

Started

Jun 2013

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult/Pediatric

Ages

14 to 32 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All of the following criteria must be met by all participants: * The participant or the participant's legal guardian is able to understand and is willing to comply with the requirements of the study * The participant meets the age requirements (14-32 years old) * The participant or legal guardian has signed an Informed Consent Form specific to this study, and is able to understand the consent form. * The participant must have English as their first language. * The participant must have a non-verbal IQ \> 70 * For the ASD/language disorder group only: * Autism Spectrum Disorder: Participants must meet criteria for Autism Spectrum Disorder on the ADOS. Exclusion Criteria: * The following exclusion criteria apply to both control and autism groups: * Any volunteer for whom informed consent cannot be obtained * Volunteers with metal braces, extensive dental work involving metals, implanted electromagnetically activated medical equipment (cardiac pacemakers, neurostimulators, functioning infusion pumps), all of which would interfere with the MEG signal, will be excluded from the MEG portion of the study * Volunteers with any medically diagnosed sensory loss * Volunteers with a known genetic disorder (e.g. Tourette's syndrome, etc), or other medical condition affecting the brain, such as progressive encephalopathy as well as those who are on high doses of multiple anti-seizure medications and have frequent, uncontrolled seizures * Asphyxia at birth or any other time, premature birth (Fewer than 34 weeks gestation) * For the control group only: * Volunteers diagnosed with a mental condition such as depression, anxiety, aggression, hyperactivity, attention deficit disorder (with or without hyperactivity). * Volunteers who score below the autism spectrum cut-off (in the normal range) on the ADOS and SCQ * Volunteers on any sort of neuro-psychopharmacological treatment (including antidepressants, stimulants, antipsychotics, anticonvulsants, benzodiazepines). * For the autism group only: * Children or adults not meeting criteria for autism spectrum disorder * Volunteers with co-morbid disorders such as tuberous sclerosis or fragile X.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Martinos Center or Biomedical Imaging

    Charlestown, Massachusetts, 02129, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.